{"id":"W2405980841","doi":"10.1186/s12872-016-0289-0","title":"Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"BMC Cardiovascular Disorders","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cardiome (Canada)","funders":"Astellas Pharma Global Development; Astellas Pharma; Cardiome Pharma Corp.","keywords":"Medicine; Atrial fibrillation; Angiology; Sinus rhythm; Cardiac surgery; Randomized controlled trial; Normal Sinus Rhythm; Internal medicine; Cardiology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002122279,0.0001556942,0.00176423,0.0001166669,0.00006575255,0.000007559938,0.00005187964,0.00006937759,0.00002576182],"category_scores_gemma":[0.003224093,0.00007911921,0.003719004,0.0001329286,0.0001259968,0.00004928603,0.00004166892,0.00002396981,0.000002210728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002579929,"about_ca_system_score_gemma":0.00006495305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004158872,"about_ca_topic_score_gemma":0.000003745813,"domain_scores_codex":[0.9982401,0.0002676123,0.0006814001,0.0002260909,0.0004392868,0.0001454949],"domain_scores_gemma":[0.9956849,0.00351541,0.0002600792,0.0003632357,0.000116226,0.00006010647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9610335,0.000007754287,0.000498431,0.00008738995,0.004004127,3.399502e-7,0.00008927009,0.00110264,0.00009202354,0.0002241548,0.00003766165,0.03282272],"study_design_scores_gemma":[0.9701196,0.0004128685,0.0008620895,0.00006769866,0.004731317,0.000002270681,0.00005848303,0.001159616,0.0001017942,0.00003478991,0.02234622,0.0001032512],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7303413,0.01138494,0.2254437,0.001806014,0.001264846,0.02942222,0.00003684864,0.0000478455,0.0002522805],"genre_scores_gemma":[0.995936,0.002458586,0.0003839366,0.00001293198,0.0009091576,0.0000210892,0.00001120679,0.00001942761,0.0002476664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2655947,"threshold_uncertainty_score":0.3859774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02142121387027996,"score_gpt":0.2931657471276077,"score_spread":0.2717445332573277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}